Triple-Negative Breast Cancer Research and Education Act of 2025

Bill 119 HR 1806, also known as the Triple-Negative Breast Cancer Research and Education Act, aims to support research and education efforts specifically focused on triple-negative breast cancer. This type of breast cancer is known for being more aggressive and harder to treat than other forms of the disease.

The bill seeks to allocate funding for research initiatives that will help improve our understanding of triple-negative breast cancer, as well as develop more effective treatment options. Additionally, the legislation aims to enhance education and awareness surrounding this particular type of breast cancer, in order to better inform patients and healthcare providers.

Overall, the Triple-Negative Breast Cancer Research and Education Act is designed to address the unique challenges posed by triple-negative breast cancer and ultimately improve outcomes for those affected by this disease.